The Use of VSL#3 in Irritable Bowel Syndrome in Children

NCT00932841 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped PI has re-located. PI terminated FDA IND # and closed study.

Conditions

Irritable Bowel Syndrome

Interventions

OTHER: Placebo
DRUG: VSL#3 900 billion bacteria
DRUG: VSL#3 90 billion bacteria

Sponsor

Dayton Children's Hospital

Collaborators

[object Object]